Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke

E-ISSN： 1996-3181|13|5|801-806

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.5, 2014-06, pp. : 801-806

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation as a Therapeutic Target in Acute Ischemic Stroke Treatment

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 14, 2009-10 ,pp. : 1240-1260

Bentham Science Publishers

Access to resources Recommend Favorite

Neuron Protection as a Therapeutic Target in Acute Ischemic Stroke

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 14, 2009-10 ,pp. : 1317-1334

Bentham Science Publishers

Access to resources Recommend Favorite

Kv1.3 potassium channels as a therapeutic target in multiple sclerosis

By Rangaraju Srikant Chi Victor Pennington Michael W Chandy K George

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 8, 2009-08 ,pp. : 909-924

Informa Healthcare

Access to resources Recommend Favorite

Osteopontin as a Potential Therapeutic Target for Ischemic Stroke

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 766-772

Bentham Science Publishers

Access to resources Recommend Favorite

Kv1.3 potassium channel blockade as an approach to insulin resistance

By Desir Gary V

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 571-579

Informa Healthcare

Access to resources Recommend Favorite